We confirmed the high tumorigenicity of SVZ-GBM cells showing increased levels of p-Akt, along with its substrate p-S6K1 (Fig. 3a) and the stemness marker CD133 (Fig. 3b), in comparison to TM-GBM cells. The gene discussed is RPS6KB1; the disease is glioblastoma.